How Top Stock Market Performers of 2018 Could Continue to Thrive in 2019

While the volatility in the market is changing to bring price drops among IPOs, some industries are managing to survive still staying at the top at the end of the last quarter of 2018 and the first quarter of 2019.

According to the chief market technician at Piper Jaffray, Craig Johnson, the winners will keep running, referring to the top performers of 2018, further adding that the health care industry managed to survive volatility levels during 2018 with bringing profits along the way, specifically pointing at the XLV sector.

That is why analysts imply that the winning sector of 2018 has a major possibility to continue to thrive despite predictions that 2019 will bring more value declines by the end.

Health Industry to Keep on Thriving in 2019 Despite the Bear Markets

According to the latest reports, health and care industry did more than just “surviving” the bear markets that came with the changing volatility in 2018, as health sector managed to end the year and enter 2019 with double digits when it comes to health care ETF like Pfizer and Merck.

As Craig Johnson from Piper Jaffray stated on the matter of success in the health care industry, it is expected to see this sector keep on thriving in 2019 as well, referring to the case that although the majority of sectors have touched new lows in February, health industry managed to stay above the lows while bringing profit.

Furthermore, on this case, the CEO of Chantico Global, Gina Sanchez, the health sector should remain bullish within the current year, while Sanchez claims that all investors should be looking for “defensive” sectors with ability to bounce off just like it is the case with health care sector in 2019.

What Sanchez is emphasizing as well, is the fact that some specific sectors within the health care industry will acquire an accelerated pace of growth, adding that biotech and digital health care will keep on thriving.

Disclaimer: The information on this site is provided for discussion purposes only, and should not be misconstrued as investment advice. Under no circumstances does this information represent a recommendation to buy or sell securities.